Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Piper Jaffray Upgrades Amgen


Amgen (AMGN) posted 82 cents second-quarter earnings per share (GAAP), and sees 2005 EPS of $3.10-$3.20. Piper Jaffray upgraded the stock on the news.

Analyst Mark Karvosky upgrades Amgen to outperform from market perform, and ups his price target to $88 on strong business trends and increased visibility into Amgen's pipeline portfolio. He expects biotechnology to be a top-performing sector in the second half of 2005. Following strong second-quarter results, he thinks the company should be a core holding for those investors looking to benefit from a rally in biotech sector.

Karvosky notes second-quarter EPS on a non-GAAP basis totaled 88 cents, vs. his 68 cents estimate, driven by strong product trends, incremental margin improvement, and other factors.

He increased his $2.83 2005 EPS estimate to $3.14, and $3.14 2006 forecast to $3.53.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus